Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angel L Montejo

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
European Psychiatry : the Journal of the Association of European Psychiatrists|December 19, 2007
Factors influencing depression endpoints research (FINDER): study design and population characteristicsAna Garcia-Cebrian, Michael Bauer, Angel L Montejo, et al.
Journal of Clinical Medicine|May 24, 2019
Frequency of Sexual Dysfunction in Patients Treated with Desvenlafaxine: A Prospective Naturalistic StudyAngel L Montejo, Joemir Becker, Gloria Bueno, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 1, 2008
Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) studyMichael Bauer, Brigitta U Monz, Angel L Montejo, et al.
Journal of Clinical Medicine|November 14, 2020
Pornography Use in Adolescents and Its Clinical ImplicationsJosep M Farré, Angel L Montejo, Miquel Agulló, et al.
Journal of Psychopharmacology (Oxford, England)|August 14, 2015
Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scaleAngel L Montejo, J F W Deakin, Raphael Gaillard, et al.
Journal of Affective Disorders|July 8, 2008
Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDERCatherine Reed, Brigitta U Monz, David G S Perahia, et al.
Annals of General Psychiatry|March 13, 2025
Physical illness in schizophrenia and the role of tolerability in antipsychotic selection: an expert consensus with a focus on cariprazineAlessandro Cuomo, Giovanni B Forleo, Taieb Ghodhbane, et al.
Schizophrenia Research|March 4, 2017
Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off valuesAkvile Bukenaite, Jan Stochl, Nilufar Mossaheb, et al.
Journal of Clinical Medicine|July 2, 2021
Validation of the Center of Applied Psychology Female Sexuality Questionnaire (CAPFS-Q)Sonia Tirado-González, Antonio Navarro-Sánchez, Antonio Compañ-Rosique, et al.
Journal of Clinical Medicine|October 13, 2021
Sexuality, Quality of Life, Anxiety, Depression, and Anger in Patients with Anal Fissure. A Case-Control StudyAntonio Navarro-Sánchez, Paloma Luri-Prieto, Antonio Compañ-Rosique, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
European Psychiatry : the Journal of the Association of European Psychiatrists|December 19, 2007
Factors influencing depression endpoints research (FINDER): study design and population characteristicsAna Garcia-Cebrian, Michael Bauer, Angel L Montejo, et al.
Journal of Clinical Medicine|May 24, 2019
Frequency of Sexual Dysfunction in Patients Treated with Desvenlafaxine: A Prospective Naturalistic StudyAngel L Montejo, Joemir Becker, Gloria Bueno, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|January 1, 2008
Prescribing patterns of antidepressants in Europe: results from the Factors Influencing Depression Endpoints Research (FINDER) studyMichael Bauer, Brigitta U Monz, Angel L Montejo, et al.
Journal of Clinical Medicine|November 14, 2020
Pornography Use in Adolescents and Its Clinical ImplicationsJosep M Farré, Angel L Montejo, Miquel Agulló, et al.
Journal of Psychopharmacology (Oxford, England)|August 14, 2015
Better sexual acceptability of agomelatine (25 and 50 mg) compared to escitalopram (20 mg) in healthy volunteers. A 9-week, placebo-controlled study using the PRSexDQ scaleAngel L Montejo, J F W Deakin, Raphael Gaillard, et al.
Journal of Affective Disorders|July 8, 2008
Quality of life outcomes among patients with depression after 6 months of starting treatment: results from FINDERCatherine Reed, Brigitta U Monz, David G S Perahia, et al.
Annals of General Psychiatry|March 13, 2025
Physical illness in schizophrenia and the role of tolerability in antipsychotic selection: an expert consensus with a focus on cariprazineAlessandro Cuomo, Giovanni B Forleo, Taieb Ghodhbane, et al.
Schizophrenia Research|March 4, 2017
Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off valuesAkvile Bukenaite, Jan Stochl, Nilufar Mossaheb, et al.
Journal of Clinical Medicine|July 2, 2021
Validation of the Center of Applied Psychology Female Sexuality Questionnaire (CAPFS-Q)Sonia Tirado-González, Antonio Navarro-Sánchez, Antonio Compañ-Rosique, et al.
Journal of Clinical Medicine|October 13, 2021
Sexuality, Quality of Life, Anxiety, Depression, and Anger in Patients with Anal Fissure. A Case-Control StudyAntonio Navarro-Sánchez, Paloma Luri-Prieto, Antonio Compañ-Rosique, et al.
Pageof 5